Sol-gel technologies to present at upcoming 2021 raymond james institutional investors conference and h.c. wainwright global life sciences conference

Ness ziona, israel, feb. 24, 2021 (globe newswire) -- sol-gel technologies (nasdaq: slgl), (“sol-gel”), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced that the company will present an overview of the company and provide a business update at the following virtual investor conferences.
SLGL Ratings Summary
SLGL Quant Ranking